{"id":42670,"date":"2023-05-02T20:50:27","date_gmt":"2023-05-03T00:50:27","guid":{"rendered":"https:\/\/www.sisinternational.com\/?page_id=42670"},"modified":"2026-05-05T15:58:25","modified_gmt":"2026-05-05T19:58:25","slug":"quest-ce-que-limagerie-medicale","status":"publish","type":"page","link":"https:\/\/www.sisinternational.com\/fr\/solutions\/etudes-de-marche-sur-les-biotechnologies-et-les-produits-pharmaceutiques-en-matiere-de-soins-de-sante-medicaux\/quest-ce-que-limagerie-medicale\/","title":{"rendered":"What Is Medical Imaging Market Research | SIS"},"content":{"rendered":"
\n

\u00c9tude de march\u00e9 sur l\u2019imagerie m\u00e9dicale<\/h1>\n
\"\u00c9tudes<\/figure>\n<\/p>\n

L\u2019imagerie m\u00e9dicale est une technique utilis\u00e9e par les professionnels de sant\u00e9. Ils l'utilisent pour examiner l'int\u00e9rieur du corps humain \u00e0 des fins diagnostiques et th\u00e9rapeutiques. Il s\u2019agit de cr\u00e9er des repr\u00e9sentations visuelles des structures internes du corps. Par exemple, il montre des images d\u2019organes, d\u2019os, de vaisseaux sanguins et de tissus. Ces images aident \u00e0 diagnostiquer et \u00e0 traiter diverses conditions m\u00e9dicales.<\/p>\n

Les techniques d\u2019imagerie m\u00e9dicale utilisent diff\u00e9rentes technologies pour capturer des images du corps. Ces technologies comprennent les rayons X, la tomodensitom\u00e9trie (TDM) et l'imagerie par r\u00e9sonance magn\u00e9tique (IRM). L\u2019\u00e9chographie et la m\u00e9decine nucl\u00e9aire sont \u00e9galement des techniques d\u2019imagerie bien connues. Ces techniques d'imagerie permettent aux prestataires de soins d'examiner les structures internes du corps. Ils peuvent obtenir des informations pr\u00e9cieuses sur la pr\u00e9sence d\u2019anomalies ou de maladies. L'imagerie m\u00e9dicale montre \u00e9galement l'emplacement, la taille et les caract\u00e9ristiques des anomalies ou des maladies.<\/p>\n

L'imagerie m\u00e9dicale est essentielle au diagnostic et \u00e0 la surveillance de diverses conditions m\u00e9dicales. Les prestataires de soins de sant\u00e9 l'utilisent pour les patients atteints de cancer, de maladies cardiovasculaires et de troubles musculo-squelettiques. C\u2019est \u00e9galement id\u00e9al pour d\u00e9tecter les troubles neurologiques et de nombreuses autres affections. Il aide les professionnels de la sant\u00e9 \u00e0 diagnostiquer les maladies, \u00e0 planifier et \u00e0 suivre le traitement. Ils l'utilisent pour guider les interventions chirurgicales et \u00e9valuer la r\u00e9ponse au traitement. L'imagerie m\u00e9dicale conduit \u00e0 de meilleurs soins aux patients et \u00e0 de meilleurs r\u00e9sultats.<\/p>\n

Pourquoi l\u2019imagerie m\u00e9dicale est-elle importante ?<\/h2>\n

L'imagerie m\u00e9dicale est importante pour le diagnostic et la d\u00e9tection. Il permet aux professionnels de la sant\u00e9 de visualiser et de d\u00e9tecter les maladies, affections et anomalies. Ces conditions peuvent ne pas \u00eatre visibles \u00e0 l'\u0153il nu. L'imagerie m\u00e9dicale permet \u00e9galement d'identifier la pr\u00e9sence, l'emplacement, la taille et les caract\u00e9ristiques des tumeurs. Les prestataires de soins de sant\u00e9 l'utilisent pour d\u00e9tecter les fractures, les infections et d'autres maladies. Un diagnostic pr\u00e9cis et pr\u00e9coce gr\u00e2ce \u00e0 l\u2019imagerie m\u00e9dicale est crucial. Cela peut avoir un impact sur les r\u00e9sultats pour les patients en permettant un traitement opportun et appropri\u00e9.<\/p>\n

L\u2019imagerie m\u00e9dicale joue un r\u00f4le crucial dans la planification et le suivi des strat\u00e9gies de traitement. Il fournit des informations d\u00e9taill\u00e9es sur l\u2019emplacement et l\u2019\u00e9tendue des maladies ou affections. Ainsi, il aide les prestataires de soins de sant\u00e9 \u00e0 \u00e9laborer des plans de traitement cibl\u00e9s. Les prestataires de soins de sant\u00e9 peuvent \u00e9galement utiliser la tomodensitom\u00e9trie, l\u2019IRM et l\u2019\u00e9chographie \u00e0 d\u2019autres fins. Par exemple, ils peuvent l\u2019utiliser pour guider des proc\u00e9dures mini-invasives. Ils peuvent alors r\u00e9aliser des biopsies et des interventions chirurgicales avec une plus grande pr\u00e9cision et des risques r\u00e9duits.<\/p>\n

L'imagerie m\u00e9dicale permet aux professionnels de la sant\u00e9 d'obtenir des images internes du corps sans proc\u00e9dures invasives. Cela r\u00e9duit le besoin de chirurgies exploratoires ou d\u2019autres techniques de diagnostic invasives. Cela minimise l'inconfort du patient, le risque de complications et le temps de r\u00e9cup\u00e9ration. La plupart des techniques d'imagerie m\u00e9dicale, telles que les rayons X, la tomodensitom\u00e9trie et l'IRM, sont s\u00fbres. Des professionnels form\u00e9s doivent les ex\u00e9cuter selon des protocoles appropri\u00e9s.<\/p>\n

L\u2019imagerie m\u00e9dicale est essentielle pour suivre l\u2019\u00e9volution du traitement. Les prestataires de soins de sant\u00e9 l\u2019utilisent \u00e9galement pour \u00e9valuer la r\u00e9ponse au traitement au fil du temps. Cela leur permet de tester l\u2019efficacit\u00e9 des th\u00e9rapies. Ils peuvent \u00e9galement l\u2019utiliser pour suivre les changements dans la taille ou les caract\u00e9ristiques des l\u00e9sions. Ils peuvent ensuite ajuster les plans de traitement selon les besoins. L\u2019imagerie m\u00e9dicale facilite \u00e9galement le suivi \u00e0 long terme des maladies chroniques. De plus, il permet de surveiller la r\u00e9cidive ou les m\u00e9tastases de maladies telles que le cancer.<\/p>\n

L'imagerie m\u00e9dicale<\/a> is an evolving field with continuous technological advancements. These advancements improve image quality. They lead to faster acquisition and new imaging modalities. The advancements also allow for more accurate and detailed visualization of internal structures. They enhance diagnostic capabilities and improve patient care.<\/p>\n

En r\u00e9sum\u00e9, l\u2019imagerie m\u00e9dicale est cruciale dans la m\u00e9decine moderne. Nous en avons besoin pour un diagnostic pr\u00e9cis et une planification du traitement. C\u2019est \u00e9galement id\u00e9al pour la surveillance et le suivi de diverses conditions m\u00e9dicales. C'est un moyen non invasif et s\u00fbr de visualiser l'int\u00e9rieur du corps. L\u2019imagerie m\u00e9dicale fournit des informations pr\u00e9cieuses aux professionnels de la sant\u00e9 pour prendre des d\u00e9cisions \u00e9clair\u00e9es. Cela leur permet de prodiguer des soins optimaux aux patients.<\/p>\n<\/div>\n

What Is Medical Imaging Market Research and How Leading Firms Use It<\/h1>\n

Medical imaging market research is the structured study of how diagnostic imaging modalities are purchased, deployed, reimbursed, and replaced across hospitals, imaging centers, and physician networks. It informs capital decisions on equipment exceeding seven figures and product strategy for OEMs, contrast agent makers, and AI software vendors competing for radiology workflow share.<\/p>\n

The category spans MRI, CT, ultrasound, X-ray, PET, SPECT, and the software stack around them: PACS, RIS, VNA, and AI-assisted reading tools. Buying centers are technical, fragmented, and slow. Decisions involve radiologists, biomedical engineering, supply chain, CFOs, and increasingly, IT security. Research that treats this as a single buyer fails. Research that maps each stakeholder by influence and veto power produces usable intelligence.<\/p>\n

Why Medical Imaging Market Research Drives Capital and Commercial Decisions<\/h2>\n

A single MRI install carries a fifteen-year revenue tail through service contracts, software upgrades, and consumables. That tail is where margin sits. Imaging OEMs that win the install rarely lose the refresh, which makes share-of-install-base the metric that determines five-year P&L. Market research that quantifies installed base by modality, age, and service contract status is the foundation of any credible commercial plan.<\/p>\n

On the buyer side, hospital systems consolidating regional imaging operations are running total-cost-of-ownership models that include uptime, throughput per hour, and tech labor cost per scan. Vendors selling on sticker price are losing to vendors selling on TCO. The shift mirrors what happened in capital equipment categories a decade earlier.<\/p>\n

<\/p>\n

SIS International Research has observed across healthcare engagements in Latin America, North America, and Western Europe that imaging procurement has moved from radiologist-led to committee-led decisions, with biomedical engineering and IT now holding effective veto authority on cybersecurity and interoperability grounds. Vendors still pitching to chief radiologists alone are losing deals they should win.<\/p>\n

<\/span><\/p>\n

The Modalities, Buyers, and Buying Centers Worth Studying<\/h2>\n

Each modality has its own economics and its own buyer. MRI and CT are capital-committee decisions weighted toward throughput and reimbursement codes. Ultrasound is point-of-care, often physician-preference driven, and increasingly bought through GPO contracts at the cart level. Mobile and portable imaging is a separate category with different distributors and different end users, including ambulatory surgery centers and skilled nursing facilities.<\/p>\n

The software layer behaves differently again. PACS and VNA replacements are IT-led with five-year RFP cycles. AI reading tools, by contrast, are radiologist-trialed and CFO-blocked, with reimbursement uncertainty driving long sales cycles. GE HealthCare, Siemens Healthineers, Philips, Canon Medical, and Fujifilm dominate the iron. The AI layer is fragmented across hundreds of FDA-cleared algorithms, with companies like Aidoc, Viz.ai, and Rad AI competing for radiologist workflow integration.<\/p>\n

Research designs that pool these segments produce averages that describe nothing. Designs that segment by modality, care setting, and decision authority produce intelligence the commercial team can act on.<\/p>\n

Methodologies That Produce Usable Intelligence<\/h2>\n

Three methodologies carry most of the weight in this category. First, B2B expert interviews with radiologists, imaging directors, biomedical engineers, and GPO contract managers. The radiologist tells you what reads well. The biomedical engineer tells you what breaks. The contract manager tells you what actually gets bought. All three are required.<\/p>\n

Second, ethnographic research inside reading rooms and scan suites. Workflow friction, hanging protocols, and time-to-diagnosis are competitive battlegrounds invisible from a survey. Watching a radiologist read a hundred studies in a shift reveals what no questionnaire captures.<\/p>\n

Third, competitive intelligence on installed base, service contract terms, and OEM trade-in offers. This data is rarely public and rarely clean. It is assembled through structured primary research with imaging directors and channel partners, then triangulated against import records, FDA 510(k) filings, and CMS reimbursement data.<\/p>\n

<\/p>\n

In a recent SIS International mixed-methodology engagement covering 200 imaging stakeholders across Brazil, the gap between stated brand preference and actual purchase behavior reached a magnitude that would mislead any vendor relying on awareness studies alone. Stated preference favored the historic market leader. Actual procurement followed service network density and Portuguese-language technical support.<\/p>\n

<\/span><\/p>\n

Where the Growth Is and What Sophisticated Buyers Are Tracking<\/h2>\n

Three vectors are reshaping commercial opportunity. AI-assisted reading is moving from pilot to procurement, with reimbursement pathways opening for stroke detection, pulmonary embolism, and breast screening. Vendors with FDA clearance and integrated PACS workflow are pulling ahead of standalone algorithm sellers.<\/p>\n

Outpatient migration is shifting volume from hospital radiology to ambulatory imaging centers and physician offices. The economics favor the operator that can run a CT at higher utilization with lower overhead. Private equity rollups in the imaging center category are accelerating this shift and creating new institutional buyers with different decision criteria.<\/p>\n

Emerging market demand is concentrated in mid-tier systems and refurbished equipment, where local service networks and financing terms outweigh imaging quality differentials at the margin. Brazil, India, Southeast Asia, and the Gulf are absorbing capacity that mature markets are retiring.<\/p>\n

\n\n\n\n\n\n\n\n\n
Modality<\/th>\nPrimary Buyer<\/th>\nDecision Cycle<\/th>\nKey Differentiator<\/th>\n<\/tr>\n<\/thead>\n
MRI \/ CT<\/td>\nCapital committee<\/td>\n12-24 months<\/td>\nThroughput, TCO, service uptime<\/td>\n<\/tr>\n
Ultrasound<\/td>\nPhysician + GPO<\/td>\n3-9 months<\/td>\nImage quality, portability, training<\/td>\n<\/tr>\n
PACS \/ VNA<\/td>\nCIO + radiology<\/td>\n18-36 months<\/td>\nInteroperability, cybersecurity<\/td>\n<\/tr>\n
AI reading tools<\/td>\nRadiologist + CFO<\/td>\n6-18 months<\/td>\nFDA clearance, reimbursement, workflow fit<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/figure>\n

Source: SIS International Research<\/em><\/p>\n

The SIS Imaging Intelligence Framework<\/h2>\n
\"\u00c9tudes<\/figure>\n

SIS structures medical imaging market research across four layers: installed base<\/strong> (what is in the field, by age and service status), decision architecture<\/strong> (who influences, who decides, who vetoes), economic logic<\/strong> (TCO, reimbursement, financing), and workflow fit<\/strong> (does the product survive a Monday morning shift). Studies that cover all four produce commercial plans that hold. Studies that cover one or two produce slides.<\/p>\n

What Separates Useful Research From Decorative Research<\/h2>\n
\"\u00c9tudes<\/figure>\n

The difference shows up in the recommendation slide. Research that names the three accounts to target next quarter, the price point that wins against the incumbent, and the service term that closes the deal earns its budget. Research that describes a market in aggregate does not. The discipline is built through fieldwork, not framework selection.<\/p>\n

Medical imaging market research at the level enterprise buyers need is fieldwork-heavy, stakeholder-segmented, and tied to a specific commercial decision. The vendors and health systems gaining share are the ones treating it that way.<\/p>\n

\u00c0 propos de SIS International<\/h2>\n

SIS International<\/a> propose des recherches quantitatives, qualitatives et strat\u00e9giques. Nous fournissons des donn\u00e9es, des outils, des strat\u00e9gies, des rapports et des informations pour la prise de d\u00e9cision. Nous menons \u00e9galement des entretiens, des enqu\u00eates, des groupes de discussion et d\u2019autres m\u00e9thodes et approches d\u2019\u00e9tudes de march\u00e9. Contactez nous<\/a> pour votre prochain projet d'\u00e9tude de march\u00e9.<\/p>\n

\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n<\/p>\n

\n

Related SIS Resources<\/h3>\n